Efficacy of retreatment with immunomodulatory drugs (IMiDs) in patients receiving IMiDs for initial therapy of newly diagnosed multiple myeloma

The efficacy of retreatment with immunomodulatory drugs (IMiDs) among patients with multiple myeloma who received this class of drugs for initial therapy is unknown. We studied 140 patients who received either thalidomide-dexamethasone (81; 58%) or lenalidomide-dexamethasone (59; 42%) as first-line...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Madan, Sumit, Lacy, Martha Q., Dispenzieri, Angela, Gertz, Morie A., Buadi, Francis, Hayman, Suzanne R., Detweiler-Short, Kristen, Dingli, David, Zeldenrust, Steven, Lust, John, Greipp, Philip R., Rajkumar, S. Vincent, Kumar, Shaji
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society of Hematology 2011
נושאים:
Clinical Trials and Observations
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3158710/
https://ncbi.nlm.nih.gov/pubmed/21673347
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-04-350009
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים